Connection

PETER JINDRA to Humans

This is a "connection" page, showing publications PETER JINDRA has written about Humans.
Connection Strength

0.280
  1. Posoleucel in Kidney Transplant Recipients with BK Viremia: Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial. J Am Soc Nephrol. 2024 May 01; 35(5):618-629.
    View in: PubMed
    Score: 0.023
  2. Reducing number of laboratories performing complement dependent cytotoxicity crossmatching: Reasons and conclusions. Hum Immunol. 2022 May; 83(5):467-475.
    View in: PubMed
    Score: 0.020
  3. Performance characteristics of chimerism testing by next generation sequencing. Hum Immunol. 2022 Jan; 83(1):61-69.
    View in: PubMed
    Score: 0.020
  4. Systemic Racism Harms Black Americans' Access to Kidney Transplantation and Full Participation in Organ Donation. Prog Transplant. 2021 12; 31(4):394-397.
    View in: PubMed
    Score: 0.020
  5. Genetic Polymorphism in Cytokines and Costimulatory Molecules in Stem Cell and Solid Organ Transplantation. Clin Lab Med. 2019 03; 39(1):107-123.
    View in: PubMed
    Score: 0.016
  6. Human Leukocyte Antigen Epitope Matching in Solid Organ Transplantation. Clin Lab Med. 2018 12; 38(4):595-605.
    View in: PubMed
    Score: 0.016
  7. Prognostic factors to predict outcome of reduced intensity allogeneic haematopoietic cell transplantation for chronic lymphocytic leukemia. Neoplasma. 2016; 63(4):595-600.
    View in: PubMed
    Score: 0.013
  8. Analysis of a Genetic Polymorphism in the Costimulatory?Molecule TNFSF4 with Hematopoietic Stem?Cell?Transplant Outcomes. Biol Blood Marrow Transplant. 2016 Jan; 22(1):27-36.
    View in: PubMed
    Score: 0.013
  9. The outcome of allogeneic HSCT in older AML patients is determined by disease biology and not by the donor type: an analysis of 96 allografted AML patients = 50 years from the Czech acute leukaemia clinical register (alert). Neoplasma. 2013; 60(5):576-83.
    View in: PubMed
    Score: 0.011
  10. Tolerance to MHC class II disparate allografts through genetic modification of bone marrow. Gene Ther. 2013 May; 20(5):478-86.
    View in: PubMed
    Score: 0.010
  11. Costimulation-dependent expression of microRNA-214 increases the ability of T cells to proliferate by targeting Pten. J Immunol. 2010 Jul 15; 185(2):990-7.
    View in: PubMed
    Score: 0.009
  12. MHC class I and integrin ligation induce ERK activation via an mTORC2-dependent pathway. Biochem Biophys Res Commun. 2008 May 02; 369(2):781-7.
    View in: PubMed
    Score: 0.008
  13. HLA class I antibody-mediated endothelial cell proliferation via the mTOR pathway. J Immunol. 2008 Feb 15; 180(4):2357-66.
    View in: PubMed
    Score: 0.008
  14. Anti-HLA antibodies can induce endothelial cell survival or proliferation depending on their concentration. Transplantation. 2006 Jul 15; 82(1 Suppl):S33-5.
    View in: PubMed
    Score: 0.007
  15. Ad-SGE-DKK3 Gene Therapy Overcomes Resistance to Immune Checkpoint Blockade in Pleural Mesothelioma. Clin Cancer Res. 2025 Jul 01; 31(13):2639-2654.
    View in: PubMed
    Score: 0.006
  16. Virtual crossmatching: Principles, practices, and the path forward-An American Society for Histocompatibility and Immunogenetics/College of American Pathologists collaborative. Am J Transplant. 2025 Oct; 25(10):2048-2056.
    View in: PubMed
    Score: 0.006
  17. Soluble mesothelin-related peptide as a prognosticator in pleural mesothelioma patients receiving checkpoint immunotherapy. J Thorac Cardiovasc Surg. 2025 Apr; 169(4):1082-1095.e4.
    View in: PubMed
    Score: 0.006
  18. Sequential vs myeloablative vs reduced intensity conditioning for patients with myelodysplastic syndromes with an excess of blasts at time of allogeneic haematopoietic cell transplantation: a retrospective study by the chronic malignancies working party of the EBMT. Bone Marrow Transplant. 2024 02; 59(2):224-231.
    View in: PubMed
    Score: 0.006
  19. Primary Graft Dysfunction in Lung Transplantation: A Review of Mechanisms and Future Applications. Transplantation. 2023 08 01; 107(8):1687-1697.
    View in: PubMed
    Score: 0.006
  20. Rare variants and HLA haplotypes associated in patients with neuromyelitis optica spectrum disorders. Front Immunol. 2022; 13:900605.
    View in: PubMed
    Score: 0.005
  21. Impact of patient: donor HLA disparity on reduced-intensity-conditioned allogeneic stem cell transplants from HLA mismatched unrelated donors for AML: from the ALWP of the EBMT. Bone Marrow Transplant. 2021 03; 56(3):614-621.
    View in: PubMed
    Score: 0.005
  22. Blastic plasmacytoid dendritic cell neoplasm: First retrospective study in the Czech Republic. Neoplasma. 2020 May; 67(3):650-659.
    View in: PubMed
    Score: 0.004
  23. Optimal Donor Selection During Verification Process: Which Factors Are Worth Knowing? Transplant Proc. 2018 Dec; 50(10):3082-3087.
    View in: PubMed
    Score: 0.004
  24. Minimal data reporting standards for serological testing for histocompatibility. Hum Immunol. 2018 Dec; 79(12):865-868.
    View in: PubMed
    Score: 0.004
  25. Comprehensive immunoproteogenomic analyses of malignant pleural mesothelioma. JCI Insight. 2018 04 05; 3(7).
    View in: PubMed
    Score: 0.004
  26. Glomerulocapillary miRNA response to HLA-class I antibody in vitro and in vivo. Sci Rep. 2017 11 06; 7(1):14554.
    View in: PubMed
    Score: 0.004
  27. Pediatric Liver Transplantation Across the ABO Blood Group Barrier: Is It an Obstacle in the Modern Era? J Am Coll Surg. 2016 Apr; 222(4):681-9.
    View in: PubMed
    Score: 0.003
  28. Impact of in vivo T-cell depletion on outcome of AML patients in first CR given peripheral blood stem cells and reduced-intensity conditioning allo-SCT from a HLA-identical sibling donor: a report from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant. 2014 Mar; 49(3):389-96.
    View in: PubMed
    Score: 0.003
  29. A prospective registration study to determine feasibility of hematopoietic SCT in adults with acute leukemia: planning, expectations and reality. Bone Marrow Transplant. 2014 Mar; 49(3):376-81.
    View in: PubMed
    Score: 0.003
  30. Glomerular mRNA expression of prothrombotic and antithrombotic factors in renal transplants with thrombotic microangiopathy. Transplantation. 2013 May 27; 95(10):1242-8.
    View in: PubMed
    Score: 0.003
  31. [The incidence of malignancies and surveillance of hematopoietic stem cells donors--the results of the Haemato-Oncology Department University Hospital in Plzen (Pilsen) and Czech National Marrow Donors Registry observation]. Klin Onkol. 2012; 25(1):42-6.
    View in: PubMed
    Score: 0.002
  32. Haematological malignancies in sibling and unrelated donors of allogeneic peripheral stem cells mobilised with G-CSF filgrastim: a transplant centre and Czech National Marrow Donors Registry experience. Bone Marrow Transplant. 2012 Jun; 47(6):867-8.
    View in: PubMed
    Score: 0.002
  33. Association of IL6 and CCL2 gene polymorphisms with the outcome of allogeneic haematopoietic stem cell transplantation. Bone Marrow Transplant. 2009 Aug; 44(4):227-35.
    View in: PubMed
    Score: 0.002
  34. Valacyclovir prophylaxis versus preemptive valganciclovir therapy to prevent cytomegalovirus disease after renal transplantation. Am J Transplant. 2008 Jan; 8(1):69-77.
    View in: PubMed
    Score: 0.002
  35. RNA interference elucidates the role of focal adhesion kinase in HLA class I-mediated focal adhesion complex formation and proliferation in human endothelial cells. J Immunol. 2007 Jun 15; 178(12):7911-22.
    View in: PubMed
    Score: 0.002
  36. Phosphorylated S6 ribosomal protein: a novel biomarker of antibody-mediated rejection in heart allografts. Am J Transplant. 2006 Jul; 6(7):1560-71.
    View in: PubMed
    Score: 0.002
  37. Anti-HLA class I antibodies activate endothelial cells and promote chronic rejection. Transplantation. 2005 Feb 15; 79(3 Suppl):S19-21.
    View in: PubMed
    Score: 0.002
  38. Anti-HLA class I antibody-mediated activation of the PI3K/Akt signaling pathway and induction of Bcl-2 and Bcl-xL expression in endothelial cells. Hum Immunol. 2004 Apr; 65(4):291-302.
    View in: PubMed
    Score: 0.001
  39. Allogeneic BMT in patients above 45 years of age: a single center experience. Bone Marrow Transplant. 2001 Apr; 27(7):723-6.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.